871P - Safety, clinical activity and biomarkers of atezolizumab (atezo) in advanced ovarian cancer (OC)
Autor: | Infante, J.R., Braiteh, F., Emens, L.A., Balmanoukian, A.S., Oaknin, A., Wang, Y., Liu, B., Molinero, L., Fasso, M., O'Hear, C., Gordon, M. |
---|---|
Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi300-vi300 |
Databáze: | ScienceDirect |
Externí odkaz: |